These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16635808)

  • 1. Biological assay challenges from compound solubility: strategies for bioassay optimization.
    Di L; Kerns EH
    Drug Discov Today; 2006 May; 11(9-10):446-51. PubMed ID: 16635808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media.
    Bard B; Martel S; Carrupt PA
    Eur J Pharm Sci; 2008 Mar; 33(3):230-40. PubMed ID: 18207706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results.
    Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN
    Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMDECOM: predicting the lifetime of screening compounds in DMSO solution.
    Zitha-Bovens E; Maas P; Wife D; Tijhuis J; Hu QN; Kleinöder T; Gasteiger J
    J Biomol Screen; 2009 Jun; 14(5):557-65. PubMed ID: 19483143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nephelometric, UV-spectroscopic, and HPLC methods for high-throughput determination of aqueous drug solubility in microtiter plates.
    Hoelke B; Gieringer S; Arlt M; Saal C
    Anal Chem; 2009 Apr; 81(8):3165-72. PubMed ID: 19317458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving accurate compound concentration in cell-based screening: validation of acoustic droplet ejection technology.
    Grant RJ; Roberts K; Pointon C; Hodgson C; Womersley L; Jones DC; Tang E
    J Biomol Screen; 2009 Jun; 14(5):452-9. PubMed ID: 19498082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming problems of compound storage in DMSO: solvent and process alternatives.
    Waybright TJ; Britt JR; McCloud TG
    J Biomol Screen; 2009 Jul; 14(6):708-15. PubMed ID: 19531665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico estimation of DMSO solubility of organic compounds for bioscreening.
    Balakin KV; Ivanenkov YA; Skorenko AV; Nikolsky YV; Savchuk NP; Ivashchenko AA
    J Biomol Screen; 2004 Feb; 9(1):22-31. PubMed ID: 15006145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a Dried-DMSO rapid throughput 24-h equilibrium solubility in advancing discovery candidates.
    Alelyunas YW; Liu R; Pelosi-Kilby L; Shen C
    Eur J Pharm Sci; 2009 May; 37(2):172-82. PubMed ID: 19429424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High throughput microsomal stability assay for insoluble compounds.
    Di L; Kerns EH; Li SQ; Petusky SL
    Int J Pharm; 2006 Jul; 317(1):54-60. PubMed ID: 16621364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemiluminescent nitrogen detection (CLND) to measure kinetic aqueous solubility.
    Kestranek A; Chervenak A; Longenberger J; Placko S
    Curr Protoc Chem Biol; 2013; 5(4):269-80. PubMed ID: 24391097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting aqueous solubility from structure.
    Delaney JS
    Drug Discov Today; 2005 Feb; 10(4):289-95. PubMed ID: 15708748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best practices in compound management for preserving compound integrity and accurately providing samples for assays.
    Matson SL; Chatterjee M; Stock DA; Leet JE; Dumas EA; Ferrante CD; Monahan WE; Cook LS; Watson J; Cloutier NJ; Ferrante MA; Houston JG; Banks MN
    J Biomol Screen; 2009 Jun; 14(5):476-84. PubMed ID: 19483144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
    Dai WG; Pollock-Dove C; Dong LC; Li S
    Adv Drug Deliv Rev; 2008 Mar; 60(6):657-72. PubMed ID: 18222563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of freeze/thaw cycles on the stability of compounds in DMSO.
    Kozikowski BA; Burt TM; Tirey DA; Williams LE; Kuzmak BR; Stanton DT; Morand KL; Nelson SL
    J Biomol Screen; 2003 Apr; 8(2):210-5. PubMed ID: 12844443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of low-volume 1536-well assay-ready compound plates.
    Eriksson H; Brengdahl J; Sandström P; Rohman M; Becker B
    J Biomol Screen; 2009 Jun; 14(5):468-75. PubMed ID: 19470713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound precipitation in high-concentration DMSO solutions.
    Popa-Burke I; Russell J
    J Biomol Screen; 2014 Oct; 19(9):1302-8. PubMed ID: 24980595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico approaches to prediction of aqueous and DMSO solubility of drug-like compounds: trends, problems and solutions.
    Balakin KV; Savchuk NP; Tetko IV
    Curr Med Chem; 2006; 13(2):223-41. PubMed ID: 16472214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.